Akèy › Rezistans Insilin › Kalifòni
Etid klinik pou Rezistans Insilin nan Kalifòni
11 etid pou Rezistans Insilin ap chèche patisipan nan sit nan Kalifòni.
Vil nan Kalifòni
Tèks ofisyèl etid la (Anglè)
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
- UCSF Medical Center at Parnassus, San Francisco
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07087184Type 1 Diabetes Extension Study
- UCSF School of Medicine, San Francisco
- Stanford University, Stanford
Ap rekriteEtid obsèvasyon
Laj 8 a 35 · Tout sèks · Mizajou Sep 18, 2026 · NCT02734277INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- Children's Hospital Los Angeles, Los Angeles
- University of California San Francisco, San Francisco
Ap rekriteFaz 2
Laj 6 a 17 · Tout sèks · Mizajou Aug 13, 2026 · NCT07224321DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- Cedars Sinai Medical Center, Los Angeles
- University of California San Francisco, San Francisco
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Jun 25, 2026 · NCT06445946Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- University of California Davis Health, Sacramento
Ap rekriteFaz 2
Laj 21 a 85 · Tout sèks · Mizajou May 6, 2026 · NCT04984226A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500
- ProSciento, Inc., Chula Vista
Ap rekriteFaz 1
Laj 18 a 60 · Tout sèks · Mizajou Apr 28, 2026 · NCT07341373Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
- Loma Linda University Cancer Center, Loma Linda
- Hoag Memorial Hospital Presbyterian, Newport
- SHARP Healthcare, San Diego
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT05455619Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
- Stanford University, Palo Alto
- Stanford University, Clinical and Translational Research Unit (CTRU), Stanford
Ap rekriteFaz 4Volontè an sante akeyi
Laj 30 a 70 · Tout sèks · Mizajou Apr 20, 2026 · NCT06657209Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
- San Francisco Research Institute, San Francisco
Ap rekriteVolontè an sante akeyi
Laj 40 a 80 · Tout sèks · Mizajou Jan 28, 2026 · NCT07220694Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
- Stanford Health, Palo Alto
Ap rekriteVolontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou Dec 4, 2024 · NCT05833217Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
- Stanford University, Stanford
Ap rekriteVolontè an sante akeyi
Laj 35 a 65 · Tout sèks · Mizajou Dec 4, 2024 · NCT05165706Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.